middle.news
Can Tryptamine’s TRP-8803 Revolutionize Binge Eating Disorder Treatment?
6:07pm on Thursday 31st of July, 2025 AEST
•
Healthcare
Read Story
Can Tryptamine’s TRP-8803 Revolutionize Binge Eating Disorder Treatment?
6:07pm on Thursday 31st of July, 2025 AEST
Key Points
World-first clinical trial for BED using TRP-8803 underway with Swinburne University
Trial to recruit 12 patients receiving two doses 14 days apart
New Chairman Herwig Janssen appointed, bringing 40+ years pharma experience
Cash position of $3.03m plus anticipated $0.8m R&D tax refund
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
TYP
OPEN ARTICLE